QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
NYSE:G

Genpact Stock Forecast, Price & News

$40.65
-0.46 (-1.12 %)
(As of 11/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$40.60
Now: $40.65
$41.15
50-Day Range
$34.01
MA: $38.67
$41.62
52-Week Range
$19.41
Now: $40.65
$45.20
Volume822,483 shs
Average Volume1.24 million shs
Market Capitalization$7.70 billion
P/E Ratio25.25
Dividend Yield0.95%
Beta1.28
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company's finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. It also provides transformation services; core industry operation services; and sourcing, procurement, and supply chain services, such as direct and indirect strategic sourcing, category management, spend analytics, procurement operations, master data management, and other procurement and supply chain advisory services. The company's IT services comprise end-user computing support, infrastructure management, application production support, and database management services, as well as business intelligence and data, enterprise resource planning, quality assurance, technology integration, and business intelligence reporting services. It serves banking, capital markets, insurance, consumer goods, retail, life sciences, healthcare, high tech, and manufacturing and services industries. Genpact Limited was founded in 1997 and is based in Hamilton, Bermuda.
Genpact logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars


Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryData Processing & Outsourced Services
CUSIPG3922B107
Phone441-294-8000
Employees96,500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.52 billion
Cash Flow$2.49 per share
Book Value$8.89 per share

Profitability

Net Income$304.88 million

Miscellaneous

Market Cap$7.70 billion
Next Earnings Date2/4/2021 (Estimated)
OptionableOptionable
$40.65
-0.46 (-1.12 %)
(As of 11/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive G News and Ratings via Email

Sign-up to receive the latest news and ratings for G and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Genpact (NYSE:G) Frequently Asked Questions

How has Genpact's stock been impacted by Coronavirus?

Genpact's stock was trading at $35.96 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, G shares have increased by 13.0% and is now trading at $40.65.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Genpact?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genpact in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Genpact
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Genpact?

Wall Street analysts have given Genpact a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Genpact wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Genpact's next earnings date?

Genpact is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Genpact
.

How were Genpact's earnings last quarter?

Genpact Limited (NYSE:G) issued its quarterly earnings data on Monday, November, 2nd. The business services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.49 by $0.07. The business services provider had revenue of $935.50 million for the quarter, compared to analyst estimates of $903.78 million. Genpact had a net margin of 8.53% and a return on equity of 22.27%. Genpact's revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.56 earnings per share.
View Genpact's earnings history
.

How often does Genpact pay dividends? What is the dividend yield for Genpact?

Genpact announced a quarterly dividend on Friday, October 23rd. Shareholders of record on Wednesday, December 9th will be paid a dividend of $0.0975 per share on Wednesday, December 23rd. This represents a $0.39 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date is Tuesday, December 8th. This is a boost from Genpact's previous quarterly dividend of $0.10.
View Genpact's dividend history
.

What guidance has Genpact issued on next quarter's earnings?

Genpact issued an update on its FY20 earnings guidance on Monday, November, 2nd. The company provided earnings per share guidance of $2.08-2.11 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.06. The company issued revenue guidance of $3.68-3.695 billion, compared to the consensus revenue estimate of $3.66 billion.

What price target have analysts set for G?

10 equities research analysts have issued 1-year price targets for Genpact's stock. Their forecasts range from $37.00 to $52.00. On average, they anticipate Genpact's stock price to reach $43.89 in the next year. This suggests a possible upside of 8.0% from the stock's current price.
View analysts' price targets for Genpact
.

Are investors shorting Genpact?

Genpact saw a increase in short interest in November. As of November 15th, there was short interest totaling 2,550,000 shares, an increase of 15.4% from the October 31st total of 2,210,000 shares. Based on an average daily volume of 948,900 shares, the short-interest ratio is currently 2.7 days. Approximately 1.5% of the shares of the stock are short sold.
View Genpact's Short Interest
.

Who are some of Genpact's key competitors?

What other stocks do shareholders of Genpact own?

Who are Genpact's key executives?

Genpact's management team includes the following people:
  • Mr. Nallicheri Vaidyanathan Tyagarajan, Pres, CEO & Director (Age 59, Pay $2.63M)
  • Mr. Edward J. Fitzpatrick CPA, Sr. VP & CFO (Age 54, Pay $1.69M)
  • Mr. Piyush Mehta, Chief HR Officer & Sr. VP (Age 51, Pay $941.26k)
  • Mr. Balkrishan Kalra, Sr. VP of Consumer Goods, Retail, Life Sciences & Healthcare (Age 50, Pay $1.55M)
  • Mr. Darren Saumur, Sr. VP & Global Operating Officer (Age 52)
  • Ms. Vidya Rao, Chief Information Officer
  • Mr. Roger Sachs C.F.A., Head of Investor Relations
  • Ms. Heather D. White, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 47)
  • Mr. Michael Schneider, VP of Integrated Communications
  • Mr. Ezra Baylin, Head of Corp. Devel. and Mergers & Acquisitions

What is Genpact's stock symbol?

Genpact trades on the New York Stock Exchange (NYSE) under the ticker symbol "G."

Who are Genpact's major shareholders?

Genpact's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.94%), Victory Capital Management Inc. (3.15%), Fenimore Asset Management Inc. (1.11%), State Street Corp (1.04%), Grandeur Peak Global Advisors LLC (0.97%) and Federated Hermes Inc. (0.85%). Company insiders that own Genpact stock include Bain Capital Investors Llc, Balkrishan Kalra, David Humphrey, Edward J Fitzpatrick, Heather White, N V Tyagarajan, Patrick Cogny and Private Ltd Gic.
View institutional ownership trends for Genpact
.

Which institutional investors are selling Genpact stock?

G stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Arrowstreet Capital Limited Partnership, Hahn Capital Management LLC, Natixis, Wells Fargo & Company MN, New York State Common Retirement Fund, Old Well Partners LLC, and Pzena Investment Management LLC. Company insiders that have sold Genpact company stock in the last year include Heather White, and Patrick Cogny.
View insider buying and selling activity for Genpact
.

Which institutional investors are buying Genpact stock?

G stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, State of Michigan Retirement System, Cubist Systematic Strategies LLC, Grandeur Peak Global Advisors LLC, Schonfeld Strategic Advisors LLC, First Trust Advisors LP, and SG Americas Securities LLC.
View insider buying and selling activity for Genpact
.

How do I buy shares of Genpact?

Shares of G can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genpact's stock price today?

One share of G stock can currently be purchased for approximately $40.65.

How big of a company is Genpact?

Genpact has a market capitalization of $7.70 billion and generates $3.52 billion in revenue each year. The business services provider earns $304.88 million in net income (profit) each year or $1.56 on an earnings per share basis. Genpact employs 96,500 workers across the globe.

What is Genpact's official website?

The official website for Genpact is www.genpact.com.

How can I contact Genpact?

Genpact's mailing address is 31 Victoria Street Victoria Place, Hamilton D0, HM 10. The business services provider can be reached via phone at 441-294-8000 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.